Exergaming for Better Physical Fitness

Not Applicable

Completed

• Conditions: Sedentary Lifestyle
• Interventions: Behavioral: Exergaming

• Registration Number: NCT04112329
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to increased physical activity, aerobic fitness and health benefits in sedentary adults. The project will include 28 sedentary adults, 18 years and above, who are not sufficiently active according to current guidelines defined as doing (\<150 minutes/week of moderate intensity physical activity or \<75 minutes/week of vigorous physical activity and/or do not do any regular endurance training ). The physical fitness (maximal oxygen consumption), blood pressure, body composition and objectively measured physical activity will be tested before and after the intervention period.

Also, the participants gaming frequency will be registered throughout the 8 week period. Aim of this study is to investigate if access to this game can provide health benefits for adults who are not motivated to take part in regular physical activity.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-09-30
• Study First Submitted QC: 2019-09-30
• Study First Posted: 2019-10-02
• Study Start: 2019-10-14
• Primary Completion: 2020-03-01
• Study Completion: 2020-03-01
• Status Verified: 2021-05
• Last Update Submitted: 2021-05-11
• Last Update Posted: 2021-05-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

• Sedentary (<150 mins of moderate intensity physical activity/week) and/or do not regularly take part in endurance training.
• Able to ride a bike for up to 60 minutes

Exclusion Criteria

• Known cardiovascular disease
• Taking beta-blockers or anti-arrhythmic drugs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Exergaming	Exergaming	Will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks

Primary Outcome Measures

Name	Time	Method
VO2max (Maximal Aerobic Capacity)	8 weeks

Secondary Outcome Measures

Name	Time	Method
Daily average number of steps	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily average energy expenditure	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Bioelectrical impedance	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (weeks).
Blood Pressure	8 weeks
Daily average total physical activity duration	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

Trial Locations

Locations (1)

Department of Circulation and Medical Imaging; 🇳🇴 Trondheim, Norway